SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Journal of Correctional Health Care
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
1078345809340424v1
15/4/292    most recent
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Reeves, R.
Right arrow Articles by Vyas, R.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Reeves, R.
Right arrow Articles by Vyas, R.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Creation of a Metabolic Monitoring Program for Second-Generation (Atypical) Antipsychotics

Rusty Reeves, MD

University Correctional HealthCare, University of Medicine and Dentistry of New Jersey, Trenton, New Jersey, reevesdo{at}umdnj.edu

Herbert Kaldany, DO

Health Services Unit, New Jersey Department of Corrections, Trenton, New Jersey

Jordan Lieberman, MD

University Correctional HealthCare, University of Medicine and Dentistry of New Jersey, Trenton, New Jersey

Rajiv Vyas, MD

University Correctional HealthCare, University of Medicine and Dentistry of New Jersey, Trenton, New Jersey

Second-generation or ‘‘atypical’’ antipsychotics can cause metabolic derangements that lead to diabetes and cardiovascular disease. To potentially minimize these adverse effects, the University of Medicine and Dentistry of New Jersey — University Correctional HealthCare (UCHC) and the New Jersey Department of Corrections (NJ DOC) created a metabolic monitoring program that was incorporated into the electronic medical record. This program is used statewide by UCHC psychiatrists working within the NJ DOC.

Key Words: metabolic syndrome • antipsychotics • medical record • correctional health care

This version was published on October 1, 2009

Journal of Correctional Health Care, Vol. 15, No. 4, 292-301 (2009)
DOI: 10.1177/1078345809340424
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?